Cara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cara Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.15 | $-0.24 | 37.5 % |
Jun 2024 | 2024-08-14 | $-0.37 | $-0.27 | -37.0 % |
Mar 2024 | 2024-05-13 | $-0.56 | $-0.40 | -40.0 % |
Dec 2023 | 2024-03-04 | $-0.59 | $-0.41 | -43.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $2.56M | $1.74M | 46.9 % |
Jun 2024 | 2024-08-14 | $991.00K | $1.17M | -15.3 % |
Mar 2024 | 2024-05-13 | $2.13M | $1.69M | 26.3 % |
Dec 2023 | 2024-03-04 | $3.00M | $9.42M | -68.1 % |
Cara Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
Cara Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.15, which beat the estimate of $-0.24.
Cara Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.